Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 1
2004 2
2005 2
2006 1
2007 3
2008 4
2009 7
2010 8
2011 3
2012 4
2013 5
2014 4
2015 4
2016 7
2017 11
2018 13
2019 7
2020 14
2021 9
2022 24
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

126 results

Results by year

Filters applied: . Clear all
Page 1
Dendrimer nanotherapy targeting of glial dysfunction improves inflammation and neurobehavioral phenotype in adult female Mecp2-heterozygous mouse model of Rett syndrome.
Khoury ES, Patel RV, O'Ferrall C, Fowler A, Sah N, Sharma A, Gupta S, Scafidi S, Kurtz JS, Olmstead SJ, Kudchadkar SR, Kannan RM, Blue ME, Kannan S. Khoury ES, et al. Among authors: kannan s. J Neurochem. 2023 Sep 30:10.1111/jnc.15960. doi: 10.1111/jnc.15960. Online ahead of print. J Neurochem. 2023. PMID: 37777475
Galactosylated hydroxyl-polyamidoamine dendrimer targets hepatocytes and improves therapeutic outcomes in a severe model of acetaminophen poisoning-induced liver failure.
Porterfield JE, Sharma R, Jimenez AS, Sah N, McCracken S, Zhang L, An HT, Lee S, Kannan S, Sharma A, Kannan RM. Porterfield JE, et al. Among authors: kannan s. Bioeng Transl Med. 2023 Feb 8;8(3):e10486. doi: 10.1002/btm2.10486. eCollection 2023 May. Bioeng Transl Med. 2023. PMID: 37206223 Free PMC article.
Dendrimer-Conjugated nSMase2 Inhibitor Reduces Tau Propagation in Mice.
Tallon C, Bell BJ, Sharma A, Pal A, Malvankar MM, Thomas AG, Yoo SW, Hollinger KR, Coleman K, Wilkinson EL, Kannan S, Haughey NJ, Kannan RM, Rais R, Slusher BS. Tallon C, et al. Among authors: kannan s. Pharmaceutics. 2022 Sep 28;14(10):2066. doi: 10.3390/pharmaceutics14102066. Pharmaceutics. 2022. PMID: 36297501 Free PMC article.
Dendrimer nanotherapy for severe COVID-19 attenuates inflammation and neurological injury markers and improves outcomes in a phase2a clinical trial.
Gusdon AM, Faraday N, Aita JS, Kumar S, Mehta I, Choi HA, Cleland JL, Robinson K, McCullough LD, Ng DK, Kannan RM, Kannan S. Gusdon AM, et al. Among authors: kannan s. Sci Transl Med. 2022 Jul 20;14(654):eabo2652. doi: 10.1126/scitranslmed.abo2652. Epub 2022 Jul 20. Sci Transl Med. 2022. PMID: 35857827 Free article. Clinical Trial.
126 results